Purchase Order 75F40122P00097
Award Date 4/13/22
Potential Completion Date 7/19/27
Potential Value $58K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Jefferson, AR 72079, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is for the service and maintenance of one Illumina MiSeq sequencing system, with a ceiling value of $34,972.40 and a performance period ending on September 24, 2024. Illumina, a for-profit organization and manufacturer of goods, has been awarded numerous prime federal contracts and...
- This is a $142,142.04 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a for-profit biotechnology manufacturer, for annual maintenance of the agency's Illumina NextSeq2000 genetic sequencing instruments. The contract does not have a set-aside designation. Illumina has two significant Indefinite Delivery Vehicles (IDVs) with the U.S. Department of Agriculture and Department of Veterans Affairs for providing a range of genomic sequencing...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $66,483.01, is for a Preventive Maintenance and Repair Agreement for an Illumina MiSeq system. The contract has an ultimate completion date of May 16, 2025 and does not utilize any set-aside designations. Illumina has been awarded numerous prime federal contracts and grants...
- This is a firm fixed-price delivery order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing technologies. The contract is for $12,450.00 to provide preventative maintenance services for Illumina's MISEQ sequencing system. The contract has an ultimate completion date of June 30, 2018 and does not utilize any set-aside designations. Illumina, headquartered in San Diego, California, is a...
- This is a $160,610.22 firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of genetic sequencing instruments and related products. The contract is for a MiSeq service agreement covering serial numbers M04729 and M06865. It does not have a set-aside designation. Illumina holds several larger federal contract vehicles with agencies like the U.S. Department of Agriculture and Department of Veterans Affairs, demonstrating its...
- This firm fixed-price purchase order contract was awarded by the Food and Drug Administration (FDA), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing technologies. The $576,928.00 contract is for the procurement of an Illumina NextSeq2000 Sequencing System, including associated reagents and maintenance services. The contract has a period of performance through July 20, 2026. Illumina is a key technology provider for federal scientific and diagnostic...
- This is a firm fixed-price delivery order awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Illumina, Inc., a for-profit manufacturer of genetic sequencing and genomic analysis technologies. The contract is for $40,567.66 and provides MiSeQ reagents and preventative maintenance services. Illumina has been awarded multiple federal contracts and Indefinite Delivery Vehicles (IDVs) from agencies such as the National Institutes of Health, Centers for Disease Control...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing instruments and related products, for the provision of a MiSeq sequencing instrument and a one-year preventative maintenance agreement. The total potential value of this contract is $109,857.00. Illumina has a history of providing sequencing systems and services to support genomic research and diagnostics across various federal...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Illumina, Inc., a for-profit manufacturer of genomic analysis technologies. The contract, with a ceiling value of $417,372.48, is for preventative maintenance services on Illumina's NextSeq 2000 and NextSeq 500 sequencing platforms. The award does not utilize a set-aside designation. Illumina is a leading provider of genetic sequencing instruments, reagents, and...
- This is a firm fixed-price delivery order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a for-profit manufacturer of genomic sequencing technologies. The contract is for the preventative maintenance of Illumina's MISEQ BENCHTOP SEQUENCER system. The total ceiling value of the contract is $225,606.45, with a period of performance ending on December 5, 2017. The contract was awarded on November 15, 2016 and did not utilize any set-aside designations. Illumina is a...